INS and coronary artery disorder: •Mediated via the gut-brain/liver axis: improves insulin sensitivity and provides cardiovascular protection •SCFAs (e.g., butyrate) regulate glucose and lipid metabolism, lower LDL cholesterol and fasting blood glucose •Significantly improves body weight and cardiovascular markers, reducing coronary heart disease risk (83)